2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
16
Lung Neoplasms
5
Carcinoma, Ovarian Epithelial
5
Carcinoma, Non-Small-Cell Lung
5
Unspecified Adult Solid Tumor, Protocol Specific
4
Squamous Cell Carcinoma of Head and Neck
4
Rectal Neoplasms
4
Prostatic Neoplasms
4
Ovarian Neoplasms
4
Head and Neck Neoplasms
4
Colorectal Neoplasms
4
Colonic Neoplasms
4
Carcinoma, Intraductal, Noninfiltrating
4
Breast Carcinoma In Situ
4
Brain Neoplasms
4
Sarcoma
3
Liver Neoplasms
3
Central Nervous System Neoplasms
3
Carcinoma, Hepatocellular
3
Salivary Gland Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Precancerous Conditions
2
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Lymphoma, Large-Cell, Anaplastic
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Gliosarcoma
2
Glioblastoma
2
Interventions
Etoposide
156
Carboplatin
146
Cisplatin
106
Topotecan
76
durvalumab
52
atezolizumab
51
Irinotecan
45
pembrolizumab
39
Paclitaxel
34
Nivolumab
33
Radiotherapy
31
PM 01183
25
Drug Therapy
24
anlotinib
23
Gemcitabine
21
apatinib
19
Ipilimumab
18
Docetaxel
17
Temozolomide
16
Platinum
16
Radiosurgery
15
Pemetrexed
14
toripalimab
13
tislelizumab
13
olaparib
13
Magnetic Resonance Spectroscopy
13
Bevacizumab
13
rovalpituzumab tesirine
11
amrubicin
11
Specimen Handling
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Small Cell Lung Carcinoma
×
Mass Spectrometry
×
Clear all
NCT00900094
2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed
200 enrolled